⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3472370 | 0.62 | — | — | |
| SCHEMBL843968 | 0.62 | — | — | |
| SCHEMBL702896 | 0.59 | — | — | |
| SCHEMBL769014 | 0.59 | — | — | |
| SCHEMBL10987530 | 0.59 | — | — | |
| SCHEMBL25473367 | 0.59 | — | — | |
| SCHEMBL3640460 | 0.59 | — | — | |
| SCHEMBL7049623 | 0.59 | — | — | |
| SCHEMBL16125856 | 0.59 | — | — | |
| SCHEMBL11431144 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114096547-A | Optically active bisphosphinylmethane, process for producing the same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2022-02-25 | — | — | CN | claimed |
| CN-114096547-B | Optically active bisphosphonylmethane, method for producing same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-114096547-B | Optically active bisphosphonylmethane, method for producing same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023133190-A2 | CATALYSTS FOR POLYLACTIDE PREPARATION | BROWN UNIVERSITY (US) | 2023-07-13 | — | — | WO | disclosed |
| CN-114096547-A | Optically active bisphosphinylmethane, process for producing the same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2022-02-25 | — | — | CN | disclosed |
| CN-114096547-A | Optically active bisphosphinylmethane, process for producing the same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2022-02-25 | — | — | CN | disclosed |
| CN-114096547-A | Optically active bisphosphinylmethane, process for producing the same, transition metal complex, and asymmetric catalyst | 日本化学工业株式会社 | 2022-02-25 | — | — | CN | disclosed |
| US-20170360811-A1 | NOVEL BISPHOSPHONIC ACID DERIVATIVE AND APPLICATION FOR SAME | NAGASAKI UNIVERSITY (JP) | 2017-12-21 | — | — | US | disclosed |
| US-20170164642-A1 | Preservative System For Acidic Beverages Based On Sequestrants | PEPSICO, INC. | 2017-06-15 | — | — | US | disclosed |
| US-8524691-B2 | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections | THE MEDICINES COMPANY (US) | 2013-09-03 | — | — | US | disclosed |
| US-20110178001-A1 | PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS CORP. (US) | 2011-07-21 | — | — | US | disclosed |
| US-7303824-B2 | Electroluminescent device | OLED-T LIMITED (GB) | 2007-12-04 | — | — | US | disclosed |
| EP-1404616-A4 | PRODUCTION OF ULTRAPURE BISMUTH-213 FOR USE IN THERAPEUTIC NUCLEAR MEDICINE | PG RES FOUNDATION INC (US) | 2006-09-13 | — | — | EP | disclosed |
| EP-1404616-A1 | PRODUCTION OF ULTRAPURE BISMUTH-213 FOR USE IN THERAPEUTIC NUCLEAR MEDICINE | PG Research Foundation, Inc. (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003000593-A1 | PRODUCTION OF ULTRAPURE BISMUTH-213 FOR USE IN THERAPEUTIC NUCLEAR MEDICINE | PG RESEARCH FOUNDATION, INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| US-4009116-A | Process of preparing substantially organic waste liquids containing radioactive or toxic substances for safe, non-pollutive handling, transportation and permanent storage | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |